- Study: China outpaces the US in cancer approvals, lags behind on first approvals<p>While China's National Medical Products Administration (NMPA) approved more oncology drugs compared to the US Food and Drug Administration (FDA) from 2020 to 2025, the US regulator approved more…raps · 4d ago↗ source
- MHRA touts uptick in approvals in 2025-2026 annual report<p>The UK's Medicines and Healthcare products Regulatory Agency (MHRA) touted its achievements over the last year its 2025-2026 annual report to Parliament, which includes approving more new drugs…raps · 4d ago↗ source
- India’s life sciences sector at turning point for innovation: ReportStructural gaps in areas including clinical execution and funding limit India’s ability to scale up innovation, according to a report from Boston Consulting Group and HealthKois.